Pharmaceuticals, patents, and politics: Canada and Bill C-22.

Pharmaceuticals, patents, and politics: Canada and Bill C-22.

Item
http://www.wikidata.org/entity/Q41094008
Research output of the Canadian pharmaceutical industry: where has all the R&D; gone?Listening for prescriptions: a national consultation on pharmaceutical policy issues.The politics behind the implementation of the WTO Paragraph 6 Decision in Canada to increase global drug access.Canadian pharmacare: looking back, looking forward.On the Nature and Strategies of Organized Interests in Health Care Policy Making.The effect of evidence-based drug coverage policies on pharmaceutical r&d: a case study from british columbiaThe road to competitive generic drug prices in Canada.Canada and access to medicines in developing countries: intellectual property rights first.Patents, brand-generic competition and the pricing of ethical drugs in Canada: some empirical evidence from British Columbia, 1981-1994
P2860

Pharmaceuticals, patents, and politics: Canada and Bill C-22.

Item
http://www.wikidata.org/entity/Q41094008
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Pharmaceuticals, patents, and politics: Canada and Bill C-22.
@en
type
label
Pharmaceuticals, patents, and politics: Canada and Bill C-22.
@en
prefLabel
Pharmaceuticals, patents, and politics: Canada and Bill C-22.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Pharmaceuticals, patents, and politics: Canada and Bill C-22.
@en
P2093
P304
P31
P356
10.2190/UCWG-YBR3-X3L0-NWYT
P433
P478
P577
P698
P921